Physician profile

Thomas G Higgins

Sleep Medicine (Psychiatry & Neurology) · Sevierville, TN

NPI 1780766469

$786.35

in general payments reported to CMS, 2019-2025

7 companies · none reported in 2025

See the full distribution for Sleep Medicine (Psychiatry & Neurology)

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$114.79

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Jazz Pharmaceuticals INC. $275.28 2019-2022
Philips North America LLC $145.87 2019-2022
Inspire Medical Systems, INC. $142.20 2020
Acclarent, INC $114.79 2023 Trudi Nav Cable, Trudi Nav Suction, Acclarent Aera
Harmony Biosciences LLC $48.86 2020-2022
Resmed Corp $32.15 2021-2022
Natus Medical Incorporated $27.20 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Thomas G Higgins

$786.35

in general payments reported 2019-2025

Years
2019-2023
Top company
Jazz Pharmaceuticals INC.

https://glasscript.com/doctor/442728/thomas-g-higgins

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.